Skip to main content
Figure 4 | Genome Medicine

Figure 4

From: Global gene expression profiling identifies new therapeutic targets in acute Kawasaki disease

Figure 4

Comparison of the gene pathway analysis of upregulated pathways in each group of patients determined by the Z test. (A) Pathways that were upregulated (KD acute vs. conv., other groups vs. healthy controls) and shared among KD, viral, and bacterial infection groups (see Additional file 2: Table S5). (B) Pathways that were shared between KD and viral infections. (C) Pathways shared by KD and bacterial infections. (D) Pathways that were specifically upregulated in KD patients and. These over-represented pathways were identified using IPA database. The numbers in each box represents the -log10 P value (BH corrected) identified by Fisher’s exact test. The colors represent the strength of association with pathways with dark red designating the highest and white the lowest level of association.

Back to article page